{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:36:23Z","timestamp":1772663783808,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401667"],"award-info":[{"award-number":["82401667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jilin Province Center for Precision Medicine Diagnosis and Treatment of Nervous System Diseases","award":["YDZJ202402026CXJD"],"award-info":[{"award-number":["YDZJ202402026CXJD"]}]},{"name":"Development of human mesenchymal stem cell exosome-loaded astaxanthin preparations and its preclinical study for the treatment of Parkinson's disease","award":["20240305084YY"],"award-info":[{"award-number":["20240305084YY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12035-025-05041-x","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:09:10Z","timestamp":1747400950000},"page":"12153-12163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying Key Plasma Proteins in the Onset of Parkinson\u2019s Disease: Proteome-Wide Mendelian Randomization and Single-Cell RNA Sequencing Analysis"],"prefix":"10.1007","volume":"62","author":[{"given":"Wei","family":"Quan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"5041_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuroscience.2020.02.046","volume":"433","author":"MS Massaquoi","year":"2020","unstructured":"Massaquoi MS, Liguore WA, Churchill MJ et al (2020) Gait deficits and loss of striatal tyrosine hydroxlase\/Trk-B are restored following 7,8-Dihydroxyflavone treatment in a progressive MPTP mouse model of Parkinson\u2019s disease. Neuroscience 433:53\u201371","journal-title":"Neuroscience"},{"issue":"1","key":"5041_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5056\/jnm17105","volume":"24","author":"AT Nair","year":"2018","unstructured":"Nair AT, Ramachandran V, Joghee NM et al (2018) Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson\u2019s disease: a critical review. J Neurogastroenterol Motil 24(1):30\u201342","journal-title":"J Neurogastroenterol Motil"},{"key":"5041_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neuroscience.2020.02.047","volume":"432","author":"I Fasciani","year":"2020","unstructured":"Fasciani I, Petragnano F, Aloisi G et al (2020) A new threat to dopamine neurons: the downside of artificial light. Neuroscience 432:216\u2013228","journal-title":"Neuroscience"},{"issue":"1","key":"5041_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"5041_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW et al (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397","journal-title":"Lancet Neurol"},{"issue":"5","key":"5041_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","volume":"127","author":"JD Elsworth","year":"2020","unstructured":"Elsworth JD (2020) Parkinson\u2019s disease treatment: past, present, and future. J Neural Transm (Vienna) 127(5):785\u2013791","journal-title":"J Neural Transm (Vienna)"},{"issue":"10291","key":"5041_CR7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303","journal-title":"Lancet"},{"issue":"9","key":"5041_CR8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, Farias FHG, Ibanez L et al (2021) Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci 24(9):1302\u20131312","journal-title":"Nat Neurosci"},{"issue":"10","key":"5041_CR9","doi-asserted-by":"publisher","first-page":"e46199","DOI":"10.1371\/journal.pone.0046199","volume":"7","author":"JC Latourelle","year":"2012","unstructured":"Latourelle JC, Dumitriu A, Hadzi TC et al (2012) Evaluation of Parkinson disease risk variants as expression-QTLs. PLoS One 7(10):e46199","journal-title":"PLoS One"},{"issue":"1","key":"5041_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-022-00551-x","volume":"17","author":"KR Bowles","year":"2022","unstructured":"Bowles KR, Pugh DA, Liu Y et al (2022) 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson\u2019s disease are associated with LRRC37A\/2 expression in astrocytes. Mol Neurodegener 17(1):48","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5041_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/genes15010046","volume":"15","author":"S Shani","year":"2023","unstructured":"Shani S, Gana-Weisz M, Bar-Shira A et al (2023) MAPT Locus in Parkinson\u2019s disease patients of Ashkenazi origin: a stratified analysis. Genes (Basel) 15(1):46","journal-title":"Genes (Basel)"},{"issue":"9","key":"5041_CR12","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.xcrm.2023.101174","volume":"4","author":"S Yuan","year":"2023","unstructured":"Yuan S, Xu F, Li X et al (2023) Plasma proteins and onset of type 2 diabetes and diabetic complications: proteome-wide Mendelian randomization and colocalization analyses. Cell Rep Med 4(9):101174","journal-title":"Cell Rep Med"},{"issue":"5","key":"5041_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00011-024-01867-8","volume":"73","author":"W Quan","year":"2024","unstructured":"Quan W, Qin Y, Li J et al (2024) Causal role of myeloid cells in Parkinson\u2019s disease: Mendelian randomization study. Inflamm Res 73(5):809\u2013818","journal-title":"Inflamm Res"},{"issue":"9","key":"5041_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.biopsych.2022.11.002","volume":"93","author":"YJ Ge","year":"2023","unstructured":"Ge YJ, Ou YN, Deng YT et al (2023) Prioritization of drug targets for neurodegenerative diseases by integrating genetic and proteomic data from brain and blood. Biol Psychiatry 93(9):770\u2013779","journal-title":"Biol Psychiatry"},{"issue":"1","key":"5041_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41531-023-00591-0","volume":"9","author":"XJ Gu","year":"2023","unstructured":"Gu XJ, Su WM, Dou M et al (2023) Expanding causal genes for Parkinson\u2019s disease via multi-omics analysis. NPJ Parkinsons Dis 9(1):146","journal-title":"NPJ Parkinsons Dis"},{"issue":"7982","key":"5041_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622(7982):329\u2013338","journal-title":"Nature"},{"issue":"12","key":"5041_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102","journal-title":"Lancet Neurol"},{"issue":"1","key":"5041_CR18","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41598-024-53287-7","volume":"14","author":"J Song","year":"2024","unstructured":"Song J, Qin Y, Wang L et al (2024) Exploring the causal relationship between B lymphocytes and Parkinson\u2019s disease: a bidirectional, two-sample Mendelian randomization study. Sci Rep 14(1):2783","journal-title":"Sci Rep"},{"issue":"12","key":"5041_CR19","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1002\/cpz1.627","volume":"2","author":"D Rasooly","year":"2022","unstructured":"Rasooly D, Peloso GM, Giambartolomei C (2022) Bayesian genetic colocalization test of two traits using coloc. Curr Protoc 2(12):e627","journal-title":"Curr Protoc"},{"issue":"W1","key":"5041_CR20","doi-asserted-by":"publisher","first-page":"W186","DOI":"10.1093\/nar\/gky474","volume":"46","author":"B Simovski","year":"2018","unstructured":"Simovski B, Kanduri C, Gundersen S et al (2018) Coloc-stats: a unified web interface to perform colocalization analysis of genomic features. Nucleic Acids Res 46(W1):W186-w193","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"5041_CR21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","volume":"94","author":"WM Su","year":"2023","unstructured":"Su WM, Gu XJ, Dou M et al (2023) Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 94(11):954\u2013961","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5041_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jprot.2013.01.025","volume":"90","author":"T Alberio","year":"2013","unstructured":"Alberio T, Bucci EM, Natale M et al (2013) Parkinson\u2019s disease plasma biomarkers: an automated literature analysis followed by experimental validation. J Proteomics 90:107\u2013114","journal-title":"J Proteomics"},{"issue":"1","key":"5041_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zeng J, Zhang F et al (2018) Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat Commun 9(1):918","journal-title":"Nat Commun"},{"issue":"3","key":"5041_CR24","first-page":"346","volume":"3","author":"J Xu","year":"2023","unstructured":"Xu J, Farsad HL, Hou Y et al (2023) Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration. Nat Aging 3(3):346\u2013365","journal-title":"Nat Aging"},{"issue":"Suppl 4","key":"5041_CR25","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1753-6561-3-S4-S10","volume":"3","author":"I Hulsegge","year":"2009","unstructured":"Hulsegge I, Kommadath A, Smits MA (2009) Globaltest and GOEAST: two different approaches for Gene Ontology analysis. BMC Proc 3(Suppl 4):S10","journal-title":"BMC Proc"},{"issue":"9","key":"5041_CR26","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"DW Huang","year":"2007","unstructured":"Huang DW, Sherman BT, Tan Q et al (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8(9):R183","journal-title":"Genome Biol"},{"issue":"D1","key":"5041_CR27","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607-d613","journal-title":"Nucleic Acids Res"},{"key":"5041_CR28","first-page":"1690341","volume":"2021","author":"W Quan","year":"2021","unstructured":"Quan W, Li J, Jin X et al (2021) Identification of potential core genes in Parkinson\u2019s disease using bioinformatics analysis. Parkinsons Dis 2021:1690341","journal-title":"Parkinsons Dis"},{"issue":"D1","key":"5041_CR29","doi-asserted-by":"publisher","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","volume":"46","author":"KC Cotto","year":"2018","unstructured":"Cotto KC, Wagner AH, Feng YY et al (2018) DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res 46(D1):D1068\u2013D1073","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5041_CR30","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour SL, Kiwala S, Cotto KC et al (2021) Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res 49(D1):D1144-d1151","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"5041_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cytogfr.2015.07.009","volume":"26","author":"M L\u00f3pez-Yoldi","year":"2015","unstructured":"L\u00f3pez-Yoldi M, Moreno-Aliaga MJ, Bustos M (2015) Cardiotrophin-1: a multifaceted cytokine. Cytokine Growth Factor Rev 26(5):523\u2013532","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"5041_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/15548627.2022.2090693","volume":"19","author":"Y Akkoc","year":"2023","unstructured":"Akkoc Y, Dalci K, Karakas HE et al (2023) Tumor-derived CTF1 (cardiotrophin 1) is a critical mediator of stroma-assisted and autophagy-dependent breast cancer cell migration, invasion and metastasis. Autophagy 19(1):306\u2013323","journal-title":"Autophagy"},{"issue":"4","key":"5041_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4183\/aeb.2022.466","volume":"18","author":"HY Ya\u015far","year":"2022","unstructured":"Ya\u015far HY, Colak A, Demirpence M et al (2022) Do androgens predict cardiovascular risk including Cardiotrophin-1 levels in patients with obese and lean polycystic ovary syndrome. Acta Endocrinol (Buchar) 18(4):466\u2013473","journal-title":"Acta Endocrinol (Buchar)"},{"key":"5041_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pbb.2013.03.003","volume":"107","author":"D Wang","year":"2013","unstructured":"Wang D, Li X, Gao K et al (2013) Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer\u2019s disease. Pharmacol Biochem Behav 107:48\u201357","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"5041_CR35","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/genes11091100","volume":"11","author":"WW Cheng","year":"2020","unstructured":"Cheng WW, Zhu Q, Zhang HY (2020) Identifying risk genes and interpreting pathogenesis for Parkinson\u2019s disease by a multiomics analysis. Genes (Basel) 11(9):1100","journal-title":"Genes (Basel)"},{"issue":"6","key":"5041_CR36","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cell.2016.04.027","volume":"165","author":"R Tewhey","year":"2016","unstructured":"Tewhey R, Kotliar D, Park DS et al (2016) Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay. Cell 165(6):1519\u20131529","journal-title":"Cell"},{"issue":"1","key":"5041_CR37","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1038\/s41467-024-50718-x","volume":"15","author":"A Doostparast Torshizi","year":"2024","unstructured":"Doostparast Torshizi A, Truong DT, Hou L et al (2024) Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson\u2019s disease. Nat Commun 15(1):6430","journal-title":"Nat Commun"},{"issue":"6","key":"5041_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/iji.12151","volume":"41","author":"J Jamshidi","year":"2014","unstructured":"Jamshidi J, Movafagh A, Emamalizadeh B et al (2014) HLA-DRA is associated with Parkinson\u2019s disease in Iranian population. Int J Immunogenet 41(6):508\u2013511","journal-title":"Int J Immunogenet"},{"issue":"4","key":"5041_CR39","first-page":"185","volume":"7","author":"MS Mo","year":"2015","unstructured":"Mo MS, Xiao YS, Wu ZH et al (2015) Association analysis of HLA-DRA in Chinese patients with sporadic Parkinson\u2019s disease. Int J Physiol Pathophysiol Pharmacol 7(4):185\u2013194","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"7","key":"5041_CR40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.parkreldis.2013.03.001","volume":"19","author":"C Ran","year":"2013","unstructured":"Ran C, Willows T, Sydow O et al (2013) The HLA-DRA variation rs3129882 is not associated with Parkinson\u2019s disease in Sweden. Parkinsonism Relat Disord 19(7):701\u2013702","journal-title":"Parkinsonism Relat Disord"},{"key":"5041_CR41","doi-asserted-by":"publisher","unstructured":"Yin KF, Chen T, Gu XJ et al (2024) Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.13652","DOI":"10.1002\/jcsm.13652"},{"issue":"6","key":"5041_CR42","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1124\/mol.117.109512","volume":"92","author":"Q Yan","year":"2017","unstructured":"Yan Q, Han C, Wang G et al (2017) Activation of AMPK\/mTORC1-mediated autophagy by metformin reverses Clk1 deficiency-sensitized dopaminergic neuronal death. Mol Pharmacol 92(6):640\u2013652","journal-title":"Mol Pharmacol"},{"key":"5041_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2016.10.018","volume":"60","author":"R Gu","year":"2017","unstructured":"Gu R, Zhang F, Chen G et al (2017) Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming. Brain Behav Immun 60:206\u2013219","journal-title":"Brain Behav Immun"},{"issue":"3","key":"5041_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jfma.2021.06.016","volume":"121","author":"HS Fang","year":"2022","unstructured":"Fang HS, Wang CC, Chao CY et al (2022) Association of ITPKB, IL1R2 and COQ7 with Parkinson\u2019s disease in Taiwan. J Formos Med Assoc 121(3):679\u2013686","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"5041_CR45","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/brainsci13081146","volume":"13","author":"S Perez-Lloret","year":"2023","unstructured":"Perez-Lloret S, Chevalier G, Bordet S et al (2023) The genetic basis of probable REM sleep behavior disorder in Parkinson\u2019s disease. Brain Sci 13(8):1146","journal-title":"Brain Sci"},{"issue":"6","key":"5041_CR46","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/medicina59061138","volume":"59","author":"E Angelopoulou","year":"2023","unstructured":"Angelopoulou E, Bougea A, Paudel YN et al (2023) Genetic insights into the molecular pathophysiology of depression in Parkinson\u2019s disease. Medicina (Kaunas) 59(6):1138","journal-title":"Medicina (Kaunas)"},{"key":"5041_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jns.2017.02.001","volume":"375","author":"J Zheng","year":"2017","unstructured":"Zheng J, Yang X, Zhao Q et al (2017) Association between gene polymorphism and depression in Parkinson\u2019s disease: a case-control study. J Neurol Sci 375:231\u2013234","journal-title":"J Neurol Sci"},{"issue":"1","key":"5041_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.31083\/j.jin.2021.01.366","volume":"20","author":"P Hua","year":"2021","unstructured":"Hua P, Cui C, Chen Y et al (2021) Thyrotroph embryonic factor polymorphism predicts faster progression of Parkinson\u2019s disease in a longitudinal study. J Integr Neurosci 20(1):95\u2013101","journal-title":"J Integr Neurosci"},{"issue":"21","key":"5041_CR49","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.4103\/0366-6999.217092","volume":"130","author":"L Li","year":"2017","unstructured":"Li L, Liu MS, Li GQ et al (2017) Relationship between apolipoprotein superfamily and Parkinson\u2019s disease. Chin Med J (Engl) 130(21):2616\u20132623","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"5041_CR50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/antiox11030524","volume":"11","author":"I Berdowska","year":"2022","unstructured":"Berdowska I, Matusiewicz M, Krzystek-Korpacka M (2022) HDL accessory proteins in Parkinson\u2019s disease-focusing on Clusterin (Apolipoprotein J) in regard to its involvement in pathology and diagnostics-a review. Antioxidants (Basel) 11(3):524","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"5041_CR51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W et al (2011) \u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10(3):230\u2013240","journal-title":"Lancet Neurol"},{"issue":"12","key":"5041_CR52","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/mds.26290","volume":"30","author":"CR Swanson","year":"2015","unstructured":"Swanson CR, Berlyand Y, Xie SX et al (2015) Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson\u2019s disease patients. Mov Disord 30(12):1648\u20131656","journal-title":"Mov Disord"},{"issue":"4","key":"5041_CR53","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s00415-017-8403-5","volume":"264","author":"F Rahmani","year":"2017","unstructured":"Rahmani F, Aarabi MH (2017) Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson? J Neurol 264(4):684\u2013693","journal-title":"J Neurol"},{"issue":"2","key":"5041_CR54","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1039\/C1AN15551B","volume":"137","author":"X Zhang","year":"2012","unstructured":"Zhang X, Yin X, Yu H et al (2012) Quantitative proteomic analysis of serum proteins in patients with Parkinson\u2019s disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. Analyst 137(2):490\u2013495","journal-title":"Analyst"},{"issue":"0 1","key":"5041_CR55","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","volume":"20","author":"LM Chahine","year":"2014","unstructured":"Chahine LM, Stern MB, Chen-Plotkin A (2014) Blood-based biomarkers for Parkinson\u2019s disease. Parkinsonism Relat Disord 20(0 1):S99-103","journal-title":"Parkinsonism Relat Disord"},{"issue":"1\u20132","key":"5041_CR56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/prca.201200087","volume":"7","author":"JT Keeney","year":"2013","unstructured":"Keeney JT, Swomley AM, F\u00f6rster S et al (2013) Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration. Proteomics Clin Appl 7(1\u20132):109\u2013122","journal-title":"Proteomics Clin Appl"},{"issue":"7","key":"5041_CR57","doi-asserted-by":"publisher","first-page":"e0181832","DOI":"10.1371\/journal.pone.0181832","volume":"12","author":"J Phie","year":"2017","unstructured":"Phie J, Krishna SM, Moxon JV et al (2017) Flavonols reduce aortic atherosclerosis lesion area in apolipoprotein E deficient mice: a systematic review and meta-analysis. PLoS One 12(7):e0181832","journal-title":"PLoS One"},{"issue":"2","key":"5041_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/mds.27204","volume":"33","author":"TF Tropea","year":"2018","unstructured":"Tropea TF, Xie SX, Rick J et al (2018) APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson\u2019s disease. Mov Disord 33(2):289\u2013297","journal-title":"Mov Disord"},{"key":"5041_CR59","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.nbd.2019.02.023","volume":"127","author":"M Shahid","year":"2019","unstructured":"Shahid M, Kim J, Leaver K et al (2019) An increased rate of longitudinal cognitive decline is observed in Parkinson\u2019s disease patients with low CSF A\u00df42 and an APOE \u03b54 allele. Neurobiol Dis 127:278\u2013286","journal-title":"Neurobiol Dis"},{"key":"5041_CR60","doi-asserted-by":"publisher","unstructured":"Davis AA, Inman CE, Wargel ZM et al (2020) APOE genotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med 12(529). https:\/\/doi.org\/10.1126\/scitranslmed.aay3069","DOI":"10.1126\/scitranslmed.aay3069"},{"issue":"9","key":"5041_CR61","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00702-011-0612-y","volume":"118","author":"C Kiyohara","year":"2011","unstructured":"Kiyohara C, Miyake Y, Koyanagi M et al (2011) APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson\u2019s disease in a Japanese population. J Neural Transm (Vienna) 118(9):1335\u20131344","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"5041_CR62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.parkreldis.2014.02.001","volume":"20","author":"SE Monsell","year":"2014","unstructured":"Monsell SE, Besser LM, Heller KB et al (2014) Clinical and pathologic presentation in Parkinson\u2019s disease by apolipoprotein e4 allele status. Parkinsonism Relat Disord 20(5):503\u2013507","journal-title":"Parkinsonism Relat Disord"},{"key":"5041_CR63","doi-asserted-by":"publisher","unstructured":"Herring SK, Moon HJ, Rawal P et al (2019) Brain clusterin protein isoforms and mitochondrial localization. Elife 8. https:\/\/doi.org\/10.7554\/eLife.48255","DOI":"10.7554\/eLife.48255"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05041-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05041-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05041-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T16:19:59Z","timestamp":1757175599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05041-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["5041"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05041-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We promise that all the datasets we used were derived from public databases, and the studies included had been approved by the relevant institutional ethics committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}